These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33407685)

  • 1. Fingolimod in children with Rett syndrome: the FINGORETT study.
    Naegelin Y; Kuhle J; Schädelin S; Datta AN; Magon S; Amann M; Barro C; Ramelli GP; Heesom K; Barde YA; Weber P; Kappos L
    Orphanet J Rare Dis; 2021 Jan; 16(1):19. PubMed ID: 33407685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental enrichment intervention for Rett syndrome: an individually randomised stepped wedge trial.
    Downs J; Rodger J; Li C; Tan X; Hu N; Wong K; de Klerk N; Leonard H
    Orphanet J Rare Dis; 2018 Jan; 13(1):3. PubMed ID: 29321033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social impairments in Rett syndrome: characteristics and relationship with clinical severity.
    Kaufmann WE; Tierney E; Rohde CA; Suarez-Pedraza MC; Clarke MA; Salorio CF; Bibat G; Bukelis I; Naram D; Lanham DC; Naidu S
    J Intellect Disabil Res; 2012 Mar; 56(3):233-47. PubMed ID: 21385260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Potential Life-Threatening Reaction to Glatiramer Acetate in Rett Syndrome.
    Nissenkorn A; Kidon M; Ben-Zeev B
    Pediatr Neurol; 2017 Mar; 68():40-43. PubMed ID: 28254244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fingolimod Modulates Dendritic Architecture in a BDNF-Dependent Manner.
    Patnaik A; Spiombi E; Frasca A; Landsberger N; Zagrebelsky M; Korte M
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fingolimod for relapsing-remitting multiple sclerosis.
    La Mantia L; Tramacere I; Firwana B; Pacchetti I; Palumbo R; Filippini G
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009371. PubMed ID: 27091121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
    Lublin F; Miller DH; Freedman MS; Cree BAC; Wolinsky JS; Weiner H; Lubetzki C; Hartung HP; Montalban X; Uitdehaag BMJ; Merschhemke M; Li B; Putzki N; Liu FC; Häring DA; Kappos L;
    Lancet; 2016 Mar; 387(10023):1075-1084. PubMed ID: 26827074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.
    Ben-Zeev B; Aharoni R; Nissenkorn A; Arnon R
    Med Hypotheses; 2011 Feb; 76(2):190-3. PubMed ID: 20951500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface- and voxel-based brain morphologic study in Rett and Rett-like syndrome with MECP2 mutation.
    Shiohama T; Levman J; Takahashi E
    Int J Dev Neurosci; 2019 Apr; 73():83-88. PubMed ID: 30690146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study.
    Tichá V; Kodým R; Počíková Z; Kadlecová P
    Clin Drug Investig; 2017 Feb; 37(2):175-186. PubMed ID: 27785735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of diabetes mellitus associated with Rett syndrome.
    Akin L; Adal E; Akin MA; Kurtoglu S
    J Pediatr Endocrinol Metab; 2012; 25(1-2):197-8. PubMed ID: 22570976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building the repertoire of measures of walking in Rett syndrome.
    Stahlhut M; Downs J; Leonard H; Bisgaard AM; Nordmark E
    Disabil Rehabil; 2017 Sep; 39(19):1926-1931. PubMed ID: 27558323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rett syndrome. Classical form and preserved speech variant as a different phenotype effect of deletion with the same starting point in MeCP2 gene - report of 2 cases].
    Stembalska A; Gil J; Pesz KA
    Med Wieku Rozwoj; 2011; 15(4):445-50. PubMed ID: 22516699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rett syndrome: 50 years' history of a still not well known condition].
    Campos-Castello J; Fernández-Mayoralas DM; Muñoz-Jareño N; San Antonio-Arce V
    Medicina (B Aires); 2007; 67(6 Pt 1):531-42. PubMed ID: 18422079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome.
    Tsai SJ
    Med Hypotheses; 2007; 68(5):1144-6. PubMed ID: 16996699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders.
    Theoharides TC; Athanassiou M; Panagiotidou S; Doyle R
    J Neuroimmunol; 2015 Feb; 279():33-8. PubMed ID: 25669997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
    Hughes R; Dalakas MC; Merkies I; Latov N; Léger JM; Nobile-Orazio E; Sobue G; Genge A; Cornblath D; Merschhemke M; Ervin CM; Agoropoulou C; Hartung HP;
    Lancet Neurol; 2018 Aug; 17(8):689-698. PubMed ID: 30001923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
    Chitnis T; Arnold DL; Banwell B; Brück W; Ghezzi A; Giovannoni G; Greenberg B; Krupp L; Rostásy K; Tardieu M; Waubant E; Wolinsky JS; Bar-Or A; Stites T; Chen Y; Putzki N; Merschhemke M; Gärtner J;
    N Engl J Med; 2018 Sep; 379(11):1017-1027. PubMed ID: 30207920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome.
    Caffarelli C; Gonnelli S; Pitinca MDT; Camarri S; Al Refaie A; Hayek J; Nuti R
    BMC Med Genet; 2020 Jan; 21(1):21. PubMed ID: 32005172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Predictors That Facilitate a Clinician's Decision to Order Genetic Testing for Rett Syndrome.
    Knight VM; Horn PS; Gilbert DL; Standridge SM
    Pediatr Neurol; 2016 Oct; 63():66-70. PubMed ID: 27473651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.